• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Topical doxorubicin hydrochloride therapy for carcinoma in situ of the bladder: a followup.

作者信息

Jakse G, Hofstädter F, Marberger H

出版信息

J Urol. 1984 Jan;131(1):41-2. doi: 10.1016/s0022-5347(17)50186-x.

DOI:10.1016/s0022-5347(17)50186-x
PMID:6690744
Abstract

A total of 10 patients with histologically proved carcinoma in situ of the bladder had remission of tumor after topical chemotherapy with doxorubicin hydrochloride for 24 months. Of the 10 patients 3 suffered new areas of carcinoma in situ 9 to 12 months after termination of intravesical chemotherapy. Furthermore, 1 of these 3 patients had a distal ureteral tumor. Fibrosis of the submucosal tissue was observed in every patient but a decrease in bladder capacity was observed in only 1 with prior radiotherapy.

摘要

相似文献

1
Topical doxorubicin hydrochloride therapy for carcinoma in situ of the bladder: a followup.
J Urol. 1984 Jan;131(1):41-2. doi: 10.1016/s0022-5347(17)50186-x.
2
Intravesical doxorubicin hydrochloride in the management of carcinoma in situ of the bladder.膀胱内注射盐酸多柔比星治疗膀胱原位癌
Eur Urol. 1980;6(2):103-6. doi: 10.1159/000473300.
3
Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma.
J Urol. 1984 Jan;131(1):43-6. doi: 10.1016/s0022-5347(17)50189-5.
4
Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later.膀胱原位癌的膀胱内化疗:5年后的情况
Eur Urol. 1984;10(5):289-93. doi: 10.1159/000463813.
5
Histological grading of carcinoma in situ of the bladder: its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy.膀胱原位癌的组织学分级:其在接受膀胱内丝裂霉素C和阿霉素序贯治疗患者中的临床意义
J Urol. 1996 Jan;155(1):94-8; discussion 98-9. doi: 10.1016/s0022-5347(01)66555-8.
6
Intracavitary doxorubicin hydrochloride treatment for carcinoma in situ of the urinary bladder. A comparative study of two therapy regimens.膀胱腔内注射盐酸多柔比星治疗膀胱原位癌。两种治疗方案的对比研究。
Eur Urol. 1981;7(2):68-72. doi: 10.1159/000473182.
7
Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder.腔内注射盐酸多柔比星治疗膀胱原位癌
J Urol. 1981 Feb;125(2):185-90. doi: 10.1016/s0022-5347(17)54959-9.
8
Intravesical therapy with adriamycin in patients with superficial bladder tumors.
Eur Urol. 1980;6(3):132-6. doi: 10.1159/000473310.
9
Topical mitomycin C therapy for carcinoma in situ of the bladder: a followup.膀胱原位癌的局部丝裂霉素C治疗:随访研究
J Urol. 1990 Jan;143(1):34-5; discussion 35-6. doi: 10.1016/s0022-5347(17)39855-5.
10
Topical mitomycin C therapy for carcinoma of the bladder.膀胱肿瘤的局部丝裂霉素C治疗
J Urol. 1987 Nov;138(5):1164-6. doi: 10.1016/s0022-5347(17)43537-3.

引用本文的文献

1
Superficial bladder cancer: state of the art.浅表性膀胱癌:最新进展
Cancer Chemother Pharmacol. 1994;35 Suppl:S101-9. doi: 10.1007/BF00686931.
2
Mechanisms of action of intravesical treatment. Effect on the ABH surface antigens of urothelial cells.
Cancer Chemother Pharmacol. 1983;11 Suppl:S74-8.
3
Methodologies for quantifying the results of intravesical chemotherapy of superficial tumors of the bladder.膀胱浅表肿瘤膀胱内化疗结果的量化方法。
Med Oncol Tumor Pharmacother. 1985;2(4):249-54. doi: 10.1007/BF02934910.